Retapamulin as a Decolonizing Agent for MRSA

NCT03304873 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

47

Enrollment

OTHER

Sponsor class

Conditions

MRSA

Interventions

DRUG: Retapamulin
DRUG: Placebo Ointment

Sponsor

NYU Langone Health